Open AccessA modern generation of drug-eluting stents. Focusing on a sirolimus-eluting stent Calypso
Author(s) -
А. Н. Кудряшов,
Д. В. Требушат,
В. В. Верин,
В. Л. Воробьев
Publication year - 2017
Publication title -
patologiâ krovoobraŝeniâ i kardiohirurgiâ/patologiâ krovoobrašeniâ i kardiohirurgiâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.136
H-Index - 3
eISSN - 2500-3119
pISSN - 1681-3472
DOI - 10.21688/1681-3472-2017-1-37-43
Subject(s) - sirolimus , stent , medicine , cardiology , drug eluting stent , restenosis
The review deals with the evolution of interventional coronary procedures and development of the state-of-art coronary stent market. Emphasis in the review is placed on comprehensive analysis of technical characteristics of the world’s most popular coronary stents versus a Russian bioresorbable sirolimus-eluting stent “Calipso”. Received 13 January 2017. Accepted 17 March 2017. Conflict of interest: Kudryashov A.N., Trebushat D.V. are “Angioline” Company employees, the producer of “Kalipso” coronary stent. Kretov E.I. served as executive editor of “Endovascular surgery” section. All other authors declare no conflict of interest.